OriGene Antibodies in recent publications
Novel HIF2A mutations disrupt oxygen sensing, leading to polycythemia, paragangliomas, and somatostatinomas Blood, Mar 2013; 121: 2563 - 2566.
Regulation of the PI3-K/Akt Survival Pathway in the Rat Endometrium Biol Reprod, Mar 2013; 88: 79.
RNA elements directing in vivo assembly of the 7SK/MePCE/Larp7 transcriptional regulatory snRNP Nucleic Acids Res., Mar 2013; 10.1093/nar/gkt159.
Ruxolitinib as potential targeted therapy for patients with JAK2 rearrangements Haematologica, Mar 2013; 98: 404 - 408.
|View All Citations >>||
Home All anti-ERK1 antibodies
Also for ERK1 (NM_001040056)
|Homo sapiens mitogen-activated protein kinase 3 (MAPK3), transcript variant 2|
|ERK-1; ERK1; ERT2; HS44KDAP; HUMKER1A; p44-ERK1; p44-MAPK; P44ERK1; P44MAPK; PRKM3|
|A 35 residue synthetic peptide, corresponding to Erk1 MAP kinase with the CGG spacer group added and the peptide coupled to KLH.|
|PBS, 0.05% BSA, 0.05% sodium azide|
|Human, Mouse, Rat, Cow, Sheep, Chicken, Drosophila, Xenopus
||WB, IHC, ICC
|Detects ~44kda and ~42kDa bands corresponding to the molecular weights of Erk1 and Erk2.|
Delta-Notch Signaling Pathway
EGFR1 Signaling Pathway
MAPK signaling pathway
TGF Beta Signaling Pathway
Toll-like receptor signaling pathway
Wnt Signaling Pathway
* Shipping is in business days
* OriGene provides validated application data and protocol, with money back guarantee.
ERK1/2 visualized using anti-ERK1, tested on Bouin's fixed paraffin embedded backskin sections of transgenic mice.